Applied Filters
Moldex-Metric hits Honeywell with false advertising suit
Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised.
PTAB invalidates Sanofi injector patent
Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi
Arthrex prevails in patent dispute over wrist fracture device
In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies.
Abbott unit prevails in dispute over catheter patent
In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.
Snyders revives patent claims against St Jude Medical
Snyders Heart Valve has been successful in reviving patent claims in an on-going dispute against St Jude Medical.
Medical tech leads 2020 innovation at the EPO
Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Federal Circuit affirms PTAB’s Baxter ruling
The US Court of Appeals for the Federal Circuit has affirmed decisions from the Patent Trial and Appeal Board, knocking out two Baxter patents.
Senator calls on Biden to reject COVID IP waiver
Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation.
India calls for IP waiver to combat COVID-19
The Indian government has called upon members of the WTO to deliver on its proposal to waive IP obligations in order to deal more effectively with the COVID-19 pandemic.
Fed Circuit cancels skin cancer detection patent
The US Court of Appeals for the Federal Circuit has cancelled claims of a Melanoscan patent covering methods of detecting skin cancer.
